Magazine Article | July 5, 2018

Dermatology — A Growth Opportunity For Those Willing To Risk Colossal Failure

Source: Life Science Leader

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

Ever experience a Phase 3 failure?

How about one resulting in a stock price drop of 80 percent?

What about a Phase 3 failure where your company’s stock price plummets 85 percent and you agree to teach about the experience (for roughly 10 years) to a class of MBA students (while continuing to work full time in industry) at one of the most prestigious business schools in the country?

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: